Tandem Diabetes Care Quarterly Cash Flow Statement
NASDAQ: TNDMHealth CareMedical/Dental InstrumentsUSD
16.11+0.435 (+2.78%)
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Tandem Diabetes Care free cash flow
In the quarter ended Jun 30, 2026, Tandem Diabetes Care generated -$34.6 million of operating cash flow and spent $4.0 million on capital expenditures. That left free cash flow of -$38.7 million, a free-cash-flow margin of -15.2% of revenue.
Summary generated from market data by MetaCap's automated system. Methodology
Tandem Diabetes Care cash flow statement (quarterly)
| Quarter (USD) | Q2 20262026-06-30 | Q1 20262026-03-31 | Q4 20252025-12-31 | Q3 20252025-09-30 | Q2 20252025-06-30 | Q1 20252025-03-31 | Q4 20242024-12-31 | Q3 20242024-09-30 | Q2 20242024-06-30 | Q1 20242024-03-31 | Q4 20232023-12-31 | Q3 20232023-09-30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | -21.17M | -20.39M | -589.00K | -21.16M | -52.40M | -130.56M | 755.00K | -23.25M | -30.81M | -42.72M | -30.00M | -32.96M |
| Net Income growth (YoY) | — | — | -178.01% | — | — | — | — | — | — | — | — | — |
| Depreciation & Amortization | 4.47M | 4.50M | 4.50M | 4.49M | 4.37M | 4.31M | 4.25M | 4.21M | 4.11M | 4.04M | 4.03M | 4.02M |
| Stock-Based Compensation | 15.74M | 15.66M | 20.11M | 21.14M | 25.64M | 25.49M | 28.17M | 26.28M | 24.90M | 22.04M | 22.74M | 20.74M |
| Change in Working Capital | -28.72M | 18.29M | -26.27M | -16.60M | -2.31M | 1.53M | -46.21M | -3.37M | -13.17M | 5.08M | -9.29M | -7.63M |
| Operating Cash Flow | -34.63M | 11.05M | 9.79M | 8.26M | -9.50M | -18.28M | 10.72M | 26.78M | -5.28M | -8.00M | -7.22M | 55.00K |
| Capital Expenditures | -4.05M | -6.27M | -6.68M | -4.09M | -6.21M | -2.96M | -3.07M | -5.24M | -6.47M | -4.46M | -5.20M | -5.40M |
| Investing Cash Flow | -87.34M | -195.45M | -14.98M | 20.54M | 58.13M | 9.19M | 5.01M | -19.90M | -3.54M | -5.06M | -16.58M | -48.52M |
| Share Repurchases | — | — | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -30.00M | — | — |
| Financing Cash Flow | 2.15M | 274.16M | 2.60M | -1.57M | -39.71M | -4.69M | 2.30M | -4.52M | -3.00M | 13.59M | 2.62M | -1.91M |
| Net Change in Cash | -116.51M | 88.69M | -1.31M | 27.84M | 10.54M | -15.66M | 20.20M | 1.34M | -11.28M | 111.00K | -20.74M | -51.14M |
| Free Cash Flow | -38.68M | 4.79M | 3.10M | 4.17M | -15.70M | -21.24M | 7.65M | 21.54M | -11.74M | -12.45M | -12.41M | -5.34M |
This table shows 12 quarterly periods of Tandem Diabetes Care's cash flow statement, from Q2 2026 back to Q3 2023, across 11 line items including net income, depreciation & amortization, stock-based compensation. Values in USD; B = billions, M = millions. Fiscal periods follow TNDM's reporting calendar. What is a cash flow statement?